Inventor · disambiguated record
Henrik Teller
Also filed as: TELLER HENRIK
15 granted patents·4 pending applications·58 citations·filing 2014–2021
91Inventor score
Top patents by PatentIndex Score
19 records- 0189US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 0288US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 0387US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 0486US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 0585US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0684US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 0782US10071995B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 11, 2018·3 cites·15 claims
- 0881US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 0979US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 1078US10167280B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Jan 1, 2019·2 cites·16 claims
- 1178US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 1274US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 1373US10414731B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 17, 2019·1 cites·6 claims
- 1472US10927109B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2017·Granted Feb 23, 2021·1 cites·19 claims
- 1559US11472803B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2021·Granted Oct 18, 2022·0 cites·3 claims
- 1651US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1745US2022144848A1Substituted oxopyridine derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 1835US2019119213A1Oxo-pyridine-derivatives as factor xia inhibitors for the treatment of thrombosisBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1934US2017298052A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henrik Teller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →